Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Anaphylaxis: still a ghost behind allergen immunotherapy.

Makatsori M, Calderon MA.

Curr Opin Allergy Clin Immunol. 2014 Aug;14(4):316-22. doi: 10.1097/ACI.0000000000000075. Review.

PMID:
24873937
2.

Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.

Calderón MA, Simons FE, Malling HJ, Lockey RF, Moingeon P, Demoly P.

Allergy. 2012 Mar;67(3):302-11. doi: 10.1111/j.1398-9995.2011.02761.x. Epub 2011 Dec 12. Review.

3.

AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions.

Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI.

J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):161-7. doi: 10.1016/j.jaip.2014.01.004.

PMID:
24607043
4.

Immunotherapy safety: what have we learned from surveillance surveys?

Kannan JA, Epstein TG.

Curr Allergy Asthma Rep. 2013 Aug;13(4):381-8. doi: 10.1007/s11882-013-0353-0. Review.

PMID:
23636820
5.

Novel routes for allergen immunotherapy: safety, efficacy and mode of action.

Moingeon P, Mascarell L.

Immunotherapy. 2012 Feb;4(2):201-12. doi: 10.2217/imt.11.171. Review.

PMID:
22339462
6.

Anaphylactic reactions during immunotherapy.

Rezvani M, Bernstein DI.

Immunol Allergy Clin North Am. 2007 May;27(2):295-307, viii. Review.

PMID:
17493504
7.

[Adverse reactions to skin tests and immunotherapy in the practice of Mexican allergologists].

Larenas Linnemann D, Rodríguez Pérez N, Becerril M.

Rev Alerg Mex. 2008 Mar-Apr;55(2):62-70. Spanish.

PMID:
19058483
8.

Systemic reactions to subcutaneous allergen immunotherapy.

Bernstein DI, Epstein T.

Immunol Allergy Clin North Am. 2011 May;31(2):241-9, viii-ix. doi: 10.1016/j.iac.2011.02.007. Review.

PMID:
21530817
9.

Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.

Caminati M, Dama AR, Djuric I, Montagni M, Schiappoli M, Ridolo E, Senna G, Canonica GW.

Expert Rev Clin Immunol. 2015 Feb;11(2):233-45. doi: 10.1586/1744666X.2015.988143. Epub 2014 Dec 6. Review.

PMID:
25484197
10.

Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: National surveillance study on allergen immunotherapy (2008-2013).

Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI.

Ann Allergy Asthma Immunol. 2016 Apr;116(4):354-359.e2. doi: 10.1016/j.anai.2016.02.001. Epub 2016 Mar 3.

PMID:
26948485
11.

An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.

Calderon MA, Casale TB, Nelson HS, Demoly P.

J Allergy Clin Immunol. 2013 Dec;132(6):1322-36. doi: 10.1016/j.jaci.2013.09.004. Epub 2013 Oct 18. Review.

PMID:
24139829
12.

Selection of patients for sublingual immunotherapy (SLIT) versus subcutaneous immunotherapy (SCIT).

Tabatabaian F, Casale TB.

Allergy Asthma Proc. 2015 Mar-Apr;36(2):100-4. doi: 10.2500/aap.2015.36.3830. Review. Erratum in: Allergy Asthma Proc. 2015 May-Jun;36(3):217.

PMID:
25715238
13.

Allergen-specific sublingual immunotherapy for respiratory allergy.

Passalacqua G, Canonica GW.

BioDrugs. 2001;15(8):509-19. Review.

PMID:
11543692
14.

Safety of sublingual immunotherapy in children.

Frati F, Ridolo E, Fuiano N, Barberi S, Dell'Albani I, Landi M, Ricciardi L, Scala G, Incorvaia C.

Expert Opin Drug Saf. 2014 Jul;13(7):947-53. doi: 10.1517/14740338.2014.918949. Epub 2014 May 12. Review.

PMID:
24821477
15.

Safety of sublingual grass pollen immunotherapy after anaphylaxis.

Nichani JR, de Carpentier J.

J Laryngol Otol. 2009 Jun;123(6):683-4. doi: 10.1017/S0022215108002879. Epub 2008 May 23.

PMID:
18501039
16.

High efficacy and absence of severe systemic reactions after venom immunotherapy.

Carballada F, Martín S, Boquete M.

J Investig Allergol Clin Immunol. 2003;13(1):43-9.

PMID:
12861850
17.

The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy.

Adamic K, Zidarn M, Bajrovic N, Erzen R, Kopac P, Music E.

Wien Klin Wochenschr. 2009;121(9-10):357-60. doi: 10.1007/s00508-009-1172-0.

PMID:
19562302
18.

Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System.

Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G.

J Allergy Clin Immunol. 2010 Mar;125(3):569-74, 574.e1-574.e7. doi: 10.1016/j.jaci.2009.10.060. Epub 2010 Feb 7. Review.

PMID:
20144472
19.

The safety of allergen immunotherapy: a literature review.

Cook PR, Farias C.

Ear Nose Throat J. 1998 May;77(5):378-9, 383-8. Review.

PMID:
9615518
20.

Supplemental Content

Support Center